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Abstract
Farnesol is a key derivative in the sterol biosynthesis pathway in eukaryotic cells previously identified as a quorum sensing
molecule in the human fungal pathogen Candida albicans. Recently, we demonstrated that above threshold concentrations,
farnesol is capable of triggering apoptosis in C. albicans. However, the exact mechanism of farnesol cytotoxicity is not fully
elucidated. Lipophilic compounds such as farnesol are known to conjugate with glutathione, an antioxidant crucial for
cellular detoxification against damaging compounds. Glutathione conjugates act as substrates for ATP-dependent ABC
transporters and are extruded from the cell. To that end, this current study was undertaken to validate the hypothesis that
farnesol conjugation with intracellular glutathione coupled with Cdr1p-mediated extrusion of glutathione conjugates,
results in total glutathione depletion, oxidative stress and ultimately fungal cell death. The combined findings demonstrated
a significant decrease in intracellular glutathione levels concomitant with up-regulation of CDR1 and decreased cell viability.
However, addition of exogenous reduced glutathione maintained intracellular glutathione levels and enhanced viability. In
contrast, farnesol toxicity was decreased in a mutant lacking CDR1, whereas it was increased in a CDR1-overexpressing
strain. Further, gene expression studies demonstrated significant up-regulation of the SOD genes, primary enzymes
responsible for defense against oxidative stress, with no changes in expression in CDR1. This is the first study describing the
involvement of Cdr1p-mediated glutathione efflux as a mechanism preceding the farnesol-induced apoptotic process in C.
albicans. Understanding of the mechanisms underlying farnesol-cytotoxicity in C. albicans may lead to the development of
this redox-cycling agent as an alternative antifungal agent.
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Introduction
Candida albicans is the most important human fungal pathogen
causing diseases varying from superficial mucosal infections to life-
threatening systemic disorders [1,2]. As a polymorphic species, C.
albicans is capable of morphological switching, a transition central
to its pathogenesis and ability to form biofilms on a variety of
surfaces, including host tissue [3–5]. Farnesol, synthesized from
farnesyl pyrophosphate, an intermediate in the sterol biosynthetic
pathway, was identified as a quorum sensing molecule secreted by
C. albicans, able to prevent yeast-to-hyphal conversion and biofilm
formation [6–9]. Recently, through assessment of classical
apoptotic markers and global proteomic analysis we demonstrated
that above threshold concentrations, farnesol induces apoptosis in
C. albicans and in human oral tumor cells [10,11]. Among the
apoptotic markers identified were the activation of intracellular
caspases, a class of proteolytic enzymes which when activated,
convey an apoptotic signal and induce apoptosis [10–12].
However, to date, the underlying mechanism of farnesol
cytotoxicity in eukaryotic cells is yet to be fully elucidated.
Apoptosis is a naturally occurring developmental process
triggered by various extracellular and intracellular stimuli. This
event causes mitochondrial membrane permeability and dissipa-
tion of the electrochemical gradient, uncoupling of the respiratory
chain and hyperproduction of superoxide anions culminating in
cell death [13,14]. Oxidative stress is well recognized as a universal
trigger for apoptosis [15]. However, apoptosis has also been
reported to be associated with glutathione depletion which may
result in oxidative stress by altering the cell reducing power with
extrusion of glutathione out of the cell [15,16]. Glutathione,
present mainly in its reduced form (GSH) is a ubiquitous thiol-
containing tripeptide composed of cysteine, glutamic acid and
glycine, synthesized in the cell by the sequential actions of a series
of six-enzyme-catalyzed reactions termed the c-glutamyl cycle
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oxidative damage through the detoxification of free radicals and
naturally occurring deleterious compounds, as well as a variety of
xenobiotics [16–18,20]. Therefore, the response of a cell to a stress
involves changes in glutathione content, which is consumed in
reactions that protect the cell by removing damaging compounds
[16].
Glutathione detoxifies xenobiotics and toxic compounds
through irreversible conjugation, concomitant with its conversion
to the oxidized form, a reaction catalyzed by glutathione
peroxidase (GPX). This reaction results in the formation of
glutathione S-conjugates which are ultimately excreted from the
cell [16,17,19]. The oxidized form, glutathione disulfide (GSSG),
normally represents ,2% of the total glutathione pool with the
reduced GSH predominating over GSSG [17,18]. Perturbations
of the GSH/GSSG ratio can affect the redox status and induce
cellular apoptosis and thus, the ratio is generally regulated tightly
to maintain cellular homeostasis [17,18]. Therefore, the intracel-
lular content of GSH is a function of the balance between
depletion and synthesis [17,18]. Cells use two competing
mechanisms to maintain low levels of GSSG and high intracellular
ratio of GSH to GSSG. The first mechanism is a recycling
reaction where GSSG is reverted to GSH by the action of the
enzyme glutathione reductase (GLR) which rapidly converts
GSSG to GSH. The second mechanism involves cellular export
of S-conjugates by membrane efflux pumps [16,17,20]. In C.
albicans, the importance of glutathione function to the growth of
the fungus was demonstrated by the studies of Baek et al. [19],
where the generation of a null mutant strain deficient in
glutathione synthesis led to an increased generation of ROS, as
well as entry into apoptosis which could be rescued by
supplementing with GSH.
In mammalian cells, the release of glutathione S-conjugates
from cells is an ATP-dependent process mediated by integral
plasma membrane glycoproteins (MRP) belonging to the ubiqui-
tous ATP-binding cassette superfamily of transporters (ABCT)
[21,22]. These transporters have been shown to export a wide
range of substrate molecules, including lipids and hydrophobic
compounds [22,23]. Many lipophilic compounds conjugated with
glutathione are substrates for the MRP family and the over-
expression of MRP1 was shown to increase ATP-dependent
glutathione S-conjugate carrier activity, whereas MRP1 inhibitors
diminish cellular extrusion of GSSG [21,24]. Therefore, these
efflux pumps play a decisive role in detoxification and defense
against oxidative stress. In C. albicans, the ABC transporter genes
CDR1 and CDR2 (Candida Drug Resistance) encode ATP-
dependent plasma membrane efflux pumps [25,26]. The overex-
pression of these genes is considered to be a major component of
antifungal drug resistance and their deletion has been shown to
result in hypersensitivity [25]. These proteins (Cdr1p and Cdr2p)
are homologues of the mammalian MRP1, sharing several
characteristics with respect to substrate binding and counteracting
inhibitory effects of endogenous metabolites [25,26]. Therefore,
due to their involvement in cellular detoxification, stress response
and drug resistance, members of this ubiquitous superfamily of
ABCT act at crossroads of vital cellular processes, constituting a
first line of defense against environmental toxins [27].
As a lipophilic hydrophobic cation and a precursor in the sterol
pathway, farnesol would classify as a compound that conjugates
with GSH, particularly given its known deleterious effect on cells
[10,11]. Therefore, conjugation of farnesol with intracellular GSH
thus disrupting the intracellular redox equilibrium would provide a
pathway ultimately leading to cellular apoptosis. However, this
potential mechanism for farnesol cytotoxicity has not been
previously investigated. To that end, in this current study, we
aimed to expand on our initial work demonstrating a farnesol-
induced apoptotic process in C. albicans. Specifically, experiments
were designed to validate the hypothesis that farnesol exerts its
cytotoxic effect by altering, either directly or indirectly, the cellular
redox status through consumption of reduced GSH, modulation of
CDR1 induction and disruption of the intracellular redox home-
ostatis predisposing the cell to apoptosis.
Materials and Methods
Strains, growth conditions and reagents
Table 1 describes the C. albicans strains used in this study.
Strains DSY448 (lacking CDR1), DSY653 (lacking CDR2) and
DSY653 (lacking CDR1 and CDR2) were constructed as previously
described by Sanglard et al. [28,29]. The Cdr1p-overexpressing
strain FL3 expressing CDR1 under the control of the HEX1
promoter and its control parent strain DL1 lacking the CDR1
construct were constructed as previously described by Niimi et al.
[30]. The wild-type strain SC5314 and CAF2-1 were used as
parent strains (CA). The CDR1 complemented strain was
constructed for this study as described below. Strains were grown
in YPD broth (Difco Laboratories, Detroit, MI) overnight at 30uC
with shaking and cells were equilibrated in fresh media to an
optical density of 1.0 at OD600. Cells were grown in YPD in the
presence of farnesol for 3 h or 18 h exposure. Cells were used at
final cell density of 2610
7 cells/ml in PBS unless otherwise stated.
Farnesol, reduced glutathione, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide, N-acetylglucosamine (GlcNAc),
Total Glutathione, Glutathione Peroxidase and Glutathione
Reductase kits were obtained from Sigma (Sigma-Aldrich
Chemical, St. Louis, MO). Farnesol was obtained as a 3 M stock
solution and diluted to a 30 mM solution in 100% methanol.
Methanol was incorporated in the control experiments however
previous experiments had shown that methanol did not have an
effect on cell viability at the concentration used in these
experiments [6,11]. To evaluate whether GSH supplementation
salvages cells from effects of farnesol, 25 mM GSH (in dH2O) was
incorporated in experiments where indicated. Reduced glutathi-
Table 1. Isogenic C. albicans strains used in this study.
Strain Genotype Parent Reference
SC5314 Wild-typ2 Gillum et al. 1984
CAF2-1 ura3D::imm434/URA3 SC5314 Fonzi et al. 1993
CAI4 ura3D::imm434/ura3D::imm434 CAF2-1 Fonzi et al. 1993
DSY448 cdr1D::hisG-URA3-hisG/cdr1D::hisG CAI4 Sanglard et al.
1996
DSY449 cdr1D::hisG/cdr1D::hisG DSY448 Sanglard et al.
1996
DSY653 cdr2D::hisG-URA3-hisG/cdr2D::hisG CAI4 Sanglard et al.
1997
DSY4310 ura3D::imm434/ura3D::imm434,
RP10::Clp10
CAI4 this work
DSY4480 cdr1D::hisG/cdr1D::hisG, RP10::Clp10 DSY449 this work
DSY4881 cdr1D::hisG/cdr1D::hisG::CDR1 DSY449 this work
FL3 cdr1D::hisG/cdr1D::hisG, pMN9131 CAI4 Niimi et al. 2004
DL1 cdr1D::hisG/cdr1D::hisG, pRC2312 CAI4 Niimi et al. 2004
doi:10.1371/journal.pone.0028830.t001
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performed on three separate occasions.
Revertant construction and confirmation of
complementation
The CDR1 gene including 815-bp upstream and 295-bp
downstream flanking regions was amplified from C. albicans
SC5314 genomic DNA with primers CDR1-SalI (59-TT-
TTGTCGACAATTTCAACAATTAACTTCA-39) and CDR1-
ApaI (59-CTTGGGCCCAATAATTCAATAATACACAATTT-
39). The resulting fragment was cloned into ClP10 [31] digested by
SalI and ApaI to yield pDS1765. This plasmid was linearized with
NsiI, which cuts within the CDR1 promoter to facilitate integration
in the CDR1 genomic locus and next transformed by a LiAc
method into the C. albicans strain DSY449, which is the ura3
derivative from DSY448 [28]. CAF4-2 and DSY449 were
transformed with CIP10 digested with StuI for integration at the
neutral RP10 locus to yield DSY4310 and DSY4480, respectively.
Complementation of CDR1 inactivation was analyzed by drug
resistance phenotype. Briefly, following selection of transformants
in YNB selective medium lacking uracil, C. albicans strains were
serially diluted in PBS and 5 ml of each dilution were deposited
onto agar plates containing 100 mg/ml fluphenazine and plates
were incubated at 35uC for 48 h. In addition, one of the positive
transformants (DSY4481) was further tested by Western analysis
following growth for 30 min in the absence or presence of
fluphenazine (20 mg/ml). Proteins were extracted from cells and
immunoblotting performed using an antibody against Cdr1p as
previously described [32]. As observed in Fig.S1A, wild type
fluphenazine susceptibility was restored in the revertant
(DSY4481). Similarly, Western analysis showed a signal corre-
sponding to Cdr1p in DSY4481 as well as the wild type control
(DSY4310) which was absent in the CDR1 mutant strain
(DSY4480) (Fig.S1B).
Total cellular glutathione content
The total cellular glutathione content was measured in farnesol-
exposed cells (2610
8 cells) in the presence and absence of
exogenous glutathione using Glutathione Assay Kit (Sigma-
Aldrich) according to manufacturer instructions. Briefly, cells were
harvested, washed with PBS and 3 volumes of 5% SSA solution
was added to the cell pellet. The suspension was frozen in liquid
nitrogen and thawed in 37uC water bath and suspension
centrifuged at 10,0006g for 10 min. 10 ml of supernatant was
used to mix with 150 ml working mixture for 5 minutes before
50 ml of NADPH was added. Absorbance at 412 nm was
monitored at 1 minute intervals for a total of 5 min. The content
of total glutathione was quantified by comparison with known
glutathione standards. Results were expressed as percent decrease
in intracellular glutathione levels in farnesol-exposed cells
compared to control cells.
MTS viability assay
Cell proliferation of farnesol-treated cells was assessed using the
MTS Tetrazolium-Based Proliferation Assay (Promega, Madison,
WI) according to manufacturer directions. Farnesol was added to
the cells at final concentrations of 10, 40, 100, 200 and 300 mMi n
the wells of a 96-well microtiter plate in PBS. Control reactions
with cells and no farnesol were included. Plates were incubated for
3 h or 18 h at 30uC with shaking. Following incubation, 20 mlo f
the MTS reagent was added to each well and plates were
incubated at 30uC for 4 h or until color fully developed. Following
color development, each sample was transferred to a fresh plate
and colorimetric change at 490 nm (A490) was measured with a
microtiter plate reader (Titertrek, Multiskan MCC1340). MTS
assay was also performed with glutathione supplementation. In
addition, C. albicans cell density and time course experiments were
also performed using the MTS assay where viability of C. albicans
was assessed at different cell densities (1610
6–2610
8 cells/ml) and
exposure times.
Viability assay by plate dilution
In addition to the MTS assay, viability of C. albicans following
increasing concentrations of farnesol was also assessed based on
colony forming units (CFU) counts. In these experiments cells were
incubated with farnesol as described above. Following incubation
360 ml of YPD broth was added to each well and 10 ml of cell
suspension was spread on YPD agar plates. Following 24 h
incubation, colonies were counted and farnesol killing was
expressed as percent killing based on decrease in CFU counts
compared to CFUs of cells not exposed to farnesol. Viability assays
were also performed with glutathione supplementation.
Overexpression of CDR1 in C. albicans
Overexpression of CDR1 was induced in C. albicans FL3 strain
as previously described [30]. Briefly, cells were grown in CSM-
URA (Bio 101, Vista, CA) medium (containing 1% glucose) at
30uC for 16 h, subcultured into the same medium at an initial
density of 2610
7 cells/ml and incubated at 30uC until cells
reached a density of 8610
7 cells/ml. Cells were then washed
three times in sterile water and resuspended at cell density of
6610
7cells/ml and starved of glucose by incubation at 30uCf o r
16 h. The cells were resuspended at cell density of 4610
7 cells/ml
in CSM-URA medium containing GlcNAc (25 mM) as carbon
source and incubated at 27uC for 1.5 h to induce the HEX1
promoter and CDR1 expression (a temperature of 27uC was used
to ensure that all cells were in the yeast morphology; expression
of CDR1 mRNA was previously shown to be induced rapidly,
within 0.5 h) [30]. Following incubation, cells were harvested,
washed and tested with farnesol in the MTS assay as described
above. The DL1 control parent strain with matched auxotrophies
but lacking the CDR1 construct was grown under identical
conditions. To check whether CDR1 overexpression conferred
resistance to fluconazole, fluconazole susceptibility testing was
performed and interpreted according to the guidelines outlined in
The National Committee for Clinical Laboratory Standards
broth microdilution protocol (NCCLS) [33]. The results demon-
strated that although both MIC values were within the
susceptible range, the MIC after induction was consistently
higher (0.5 mg/ml) than that for the strain prior to induction
(0.25 mg/ml) or to CA on all occasions tested.
To confirm the overexpression of CDR1, gene expression studies
were performed on RNA extracted from FL3 and DL1 strains
following the induction procedure. Analysis was also performed on
CA and cdr1 strains. RT-PCR was performed as described below
in Gene Expression section.
GSH/GSSG homeostatis and redox balance
Farnesol-induced disruption in intracellular redox balance was
assessed using the GSH/GSSG, performed as previously described
by Gonzalez-Parraga et al. [34] with some modifications. Briefly,
cells were exposed to farnesol in PBS for 3 h and 18 h. Farnesol-
exposed cells were harvested at the indicated times, washed and
resuspended in 2 ml of cold 5% meta-phosphoric acid. The
cellular suspensions were transferred into small pre-cooled tubes
with glass beads in a bead beater and were subjected to 6 cycles of
45 seconds each. Following centrifugation at 10000 g for 5 min,
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phosphate buffer (pH 7.5) and 25 mlo fd H 2O. This sample was
used for total glutathione assay. Another 500 ml of supernatant was
mixed with 750 ml of 0.5 M K-phosphate buffer (pH7.5) and 25 ml
of 2-vivylpyridine until an emulsion was formed and samples were
incubated for 1 h at room temperature. Following incubation,
150 ml mixture of 0.2 mM NADPH, 50 M K-phosphate buffer
(pH7.5), 5 mM EDTA, 0.6 mM DTNB and 3 units of glutathione
reductase enzyme was mixed with 5 ml of extracted samples in 96-
well microtiter plates. The reaction rate was monitored by
measuring the change in absorbance at 412 nm for 1 min and a
standard curve was developed based on glutathione in the range of
0–100 mmol/ml.
Confocal scanning laser microscopy
Experiments were performed on cells exposed to 40 and
200 mM farnesol for 3 h and 18 h. For these experiments, cells
were grown in YPD at final cell density of 2610
7 cells/ml in the
presence and absence of farnesol or exogenous reduced GSH.
Following incubation at 30uC with shaking, cells were harvested,
washed in PBS and processed for ROS accumulation and caspase
activation and observed with a Zeiss Axiovert 100 confocal
microscope (with video capture system, automatic camera and
image analysis hardware and software) using 206,4 0 6and 1006
oil immersion objectives. Imaging of stained cells was accom-
plished by using a Cy2/Cy3 multitrack filter set. Images were
processed for display by using Axiovision 3.6 software (Zeiss).
Quantification was performed by scoring green fluorescent cells
(ROS accumulation, caspase activation) and red fluorescent cells
(necrotic cells) relative to all cells in 10 fields.
ROS accumulation
Accumulation of intracellular reactive oxygen species (ROS)
was assayed using a mixture of 100 ml of the fluorescent probe
dichlorodihydrofluorescein diacetate (5 mM in EtOH) (DCDHF-
DA; Molecular Probes), 100 ml of the chitin-binding stain
calcofluor white (1 mg/ml) (Sigma-Aldrich) which allows visual-
ization of all healthy cells and propidium iodide (Sigma-Aldrich)
which stains dead cells. The mixture (4.5 ml) was added to cells and
incubated for 30 min in the dark. Following incubation, cells were
collected by centrifugation (5 min, 40006 g), washed with PBS
and re-suspended in 50 ml PBS.
Detection of caspase activation
Activated caspases in the farnesol-exposed cells with and
without glutathione supplementation were detected microscopi-
cally using FLICA Apoptosis Detection Kits (Immunochemistry
Technologies, LLC, Bloomington, MN) according to manufactur-
er directions. Cells with intracellular active caspases fluoresce
green whereas non-apoptotic cells appear unstained.
Glutathione peroxidase (GPX) activity
Glutathione peroxidase activity in 3 h or 18 h farnesol-
exposed cells in the presence and absence of exogenous
glutathione was measured using the colorimetric Glutathione
Peroxidase Cellular Activity Assay Kit (Sigma) according to
manufacturer directions. The reaction is based on the reduction
of hydrogen peroxide and organic peroxides to the correspond-
ing stable alcohols and water by cellular glutathione in the
presence of glutathione peroxidase. Cells (2610
8)w e r er e s u s -
pended in 100 ml of assay buffer and cell suspension was frozen
in liquid nitrogen and thawed at 37uC twice then centrifuged at
100006g for 10 min. Supernatant was recovered and 50 mlo f
the sample was mixed with 0.25 mM NADPH and 0.21 mM
reduced glutathione and 0.5 units/ml glutathione reductase in
buffer. The reaction was started by 300 mM t-Bu-OOH.
Absorbance at 340 nm was recorded at 10 seconds interval for
6 times after 15 seconds initial delay. The activity of glutathione
peroxidase in the sample expressed in mmol/min/ml was
calculated using the formula: (Dblank-Dsample)/(e
mM60.05), where
e
mM=6.22.
Glutathione reductase (GLR) activity
Glutathione reductase activity in 3 h or 18 h farnesol-exposed
cells in the presence and absence of exogenous glutathione was
measured using the colorimetric Glutathione Reductase Assay Kit
(Sigma) according to manufacturer directions based on the
reduction of GSSG to GSH by NADPH in the presence of
glutathione reductase with controls included. 2610
8 cells were re-
suspended in 100 ml of assay buffer. The cell suspension was frozen
in liquid nitrogen and thawed at 37uC twice then centrifuged at
100006g for 10 min. Supernatant was recovered and 50 ml of the
sample was mixed with 2 mM Oxidized Glutathione and 3 mM
DTNB in buffer. The reaction was started by the addition of
2 mM NADPH. Absorbance at 412 nm was reported at
10 seconds intervals for a total of 11 readings. The concentration
of the enzyme reported as mmol/min/ml/10
8 cells was calculated
using the formula above.
Gene expression analysis
For detection of gene transcripts, gene-specific primer pairs
(Table 2) were designed based on gene sequences in GenBank.
Total RNA was isolated from cultures using an InvisorbH Spin
Cell Total RNA mini kit (Invitek, Berlin, Germany) after grinding
cells in liquid nitrogen. DNA was removed by DNase (New
England Biolabs) treatment followed by clean up using the RNeasy
protocol (Qiagen Benelux BV, Venlo, The Netherlands). The
RNA concentration was determined using a Nanodrop UV/VIS
spectrophotometer (Isogen-Biosolutions Inc., Maarsen, The Neth-
erlands). Absence of genomic DNA was confirmed by performing
Table 2. Primer sequences used in RT-PCR.
Primer name Sequence (59-to-39)
EFB1-F GAACGAATTCTTGGCTGAC
EFB1-B CATCAGAACCGAACAAGTC
CDR1-F GAATCGGGATTCAATTGGTC
CDR1-B GAATCGGGATTCAATTGGTC
SOD1-F TTGAACAAGAATCCGAATCC
SOD1-B AGCCAATGACACCACAAGCAG
SOD2-F ACCACCCGTGCTACTTTGAAC
SOD2-B GCCCATCCAGAACCTTGAAT
SOD3-F ACAATGCCGCTATTGACGCA
SOD3-B AGCCCAGTTGATCACGTTCCA
SOD4-F CCAGTGAATCATTTGAAGTTG
SOD4-B AGAAGCACTAGTTGATGAACC
GLR1-F AATTGGTGTTTTCCGCTGAC
GLR1-B AACCCCAATGTAACCAGCAC
GPX2-F TGTGTGGGTTCACACCTCAA
GPX2-B ATGGGGAAACTGACACCAAA
doi:10.1371/journal.pone.0028830.t002
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transcription step. Reverse transcription was performed on 1 mg
of total RNA using an iScript
TM cDNA synthesis kit (Biorad,
Veenendaal, the Netherlands) as specified. Synthesized cDNA
was diluted 1:20 in DEPC treated water and stored at 280uC
until needed. Sample preparation was performed using a CAS-
1200
TM pipetting robot (Corbett Life Science, Sydney, Australia).
Real time PCR was performed on a MyCycler real time
thermocycler (Biorad, Veenendaal, the Netherlands) using
ABsolute QPCR SYBR Green mix (Abgene, Epsom, United
Kingdom) and primer pairs listed in Table 2. Amplification was
achieved using the following cycle settings: 15 min 95uC followed
by 35 cycles of 95uC 1 min, 58uC3 0s ,7 2 uC 30 s. After the
amplification a melt curve was analyzed to ensure the absence of
primer dimers. Expression was calculated using the ACT1 as
reference gene.
In addition to qRT-PCR, gene expression analysis was also
performed using cDNA synthesis/RT-PCR. Reactions were
analyzed on a 1% agarose gels containing 0.5grams/ml ethidium
bromide and bands were visualized with a MultiImager scanner
(Bio-Rad Laboratories, Hercules California) and images analyzed
with the PDQuest version 7.0 (BioRAd).
Statistical analysis
All experiments were performed in triplicate on 3 different
occasions. Student’s t-Test was employed to assess the statistical
significance of treated versus untreated samples along with
standard error. A statistically significant difference was considered
to be present at p,0.05.
Results
Effect of farnesol on CDR1 gene expression
To determine whether farnesol exposure modulates the
expression of the efflux pump CDR1, gene expression studies
were performed. Results from these experiments demonstrated
that farnesol exposure resulted in significant increase in the
expression of CDR1 relative to the untreated control cells (Fig. 1).
This increase in expression was not changed by the addition of
GSH (data not shown). The profile of gene expression was similar
to that obtained by RT-PCR analysis (data not shown).
Total cellular glutathione content
As conjugation of farnesol with reduced GSH is expected to
deplete its levels, the total cellular glutathione concentration was
comparatively measured in control (100%) and farnesol-exposed
cells. Results demonstrated that farnesol exposure resulted in
significant decrease (p,0.05) in total cellular glutathione content
proportional to farnesol concentration and time of exposure with
maximum drop of .50% noted at 18 h exposure to 200 mM
farnesol. However, the drop in glutathione levels in CA was
inhibited upon supplementation of exogenous GSH at 3 h,
whereas at 18 h exposure, the drop was only 18% compared to
the initial 50% in the absence of glutathione (Fig. 2A). In
contrast, cdr1 demonstrated sustained levels of intracellular
glutathione in the presence of farnesol with a slight drop at
200 mM farnesol which was restored to normal in the presence of
glutathione.
MTS viability assay
The MTS metabolic assay was performed to assess farnesol’s
killing effect on C. albicans. Cell proliferation following exposure to
increasing concentrations of farnesol (10, 40, 100 and 200 mM)
was assessed by measuring absorbance following color develop-
ment. Results indicated a significant (p,0.05) killing effect for
farnesol on CA proportional to farnesol concentration and
exposure time with maximum killing at 18 h exposure to
200 mM. Although the trend was similar, the killing of cdr1 was
significantly less (p,0.05) drastic. However, no or minimal killing
was observed with either strain upon glutathione supplementation
(Fig. 2B). To confirm the involvement of CDR1 in farnesol-
dependent killing, viability assays were also performed on the
CDR1-complemented strain which exhibited approximately 52%
killing at 100F following 3 h exposure, a profile similar to that for
the wild type strain (,58% killing) and control strain (,59%
killing) compared to cdr1 (,38% killing). The similarity in farnesol-
dependent killing between the revertant and wild type strains was
also consistent under all conditions tested (different farnesol
concentrations and exposure times) confirming successful comple-
mentation of CDR1.
Assays using various C. albicans cell density as well as time course
killing experiments were also performed. Results from these
experiments demonstrated that C. albicans killing was inversely
proportional to its cell density (Fig. S2) and proportional to time of
exposure to farnesol (Fig. S3).
Viability assay by plate dilution
In addition to the MTS metabolic assay C. albicans viability was
also assessed using plate dilution and colony forming units (CFU)
counts. The results based on percent killing from these
experiments demonstrated a similar farnesol-dependent killing
effect on C. albicans (Fig. S4). Viability assays using plating were
also performed with glutathione supplementation. CFU counts
confirmed the ability of exogenous glutathione to reduce the
Figure 1. Effect of farnesol on the expression of CDR1 in CA
following 3 and 18 h exposure to increasing concentrations of
farnesol. Farnesol-concentration and exposure time-dependent up-
regulation of CDR1. Expression is normalized against ACT1 expression.
Data represent the average of 3 independent experiments performed in
triplicate. Error bars indicate the standard errors of the means. p,0.05.
doi:10.1371/journal.pone.0028830.g001
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times tested (Fig. S4).
Overexpression of CDR1
To confirm the involvement of CDR1 in farnesol cytotoxicity,
the effect of farnesol on a strain overexpressing CDR1 was tested.
C. albicans FL3 and DL1 cells were grown in medium containing
GlcNAc as carbon source to induce the HEX1 promoter and the
expression of CDR1. Results from the MTS assay demonstrated
that at 100F the CDR1 overexpressing strain exhibited approxi-
mately 30% enhanced susceptibility to farnesol compared to wild-
type and over 50% increase compared to its control strain DL1
and cdr1 (Fig. 3).
The overexpression of CDR1 in the FL3 strain was confirmed by
RT-PCR analysis where gene expression analysis demonstrated
significant increase in CDR1 expression in the induced FL3 strain
compared to the wild-type whereas, as expected, no expression
was seen in the cdr1 and DL1 strains (Fig. S5).
Figure 2. Effect of farnesol on intracellular glutathione levels and viability in CA and cdr1 in the presence and absence of
exogenous glutathione following 3 h and 18 h exposure to increasing farnesol concentrations. (A) Significant decrease in glutathione
levels in CA proportional to farnesol concentration and time of exposure with minimal decrease in glutathione in cdr1. Exogenous glutathione (G)
inhibited drop in intracellular levels in both strains. Error bars indicate the standard errors of the means. (B) Farnesol concentration and exposure
time-dependent killing of C. albicans with cdr1 exhibiting decreased susceptibility. However, no killing was observed upon supplementation with
exogenous glutathione (G). Error bars indicate the standard errors of the means.
doi:10.1371/journal.pone.0028830.g002
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No significant changes in reduced GSG and GSSG content
were noted when cells where exposed to farnesol for 3 h.
However, significant changes were noted following 18 h exposure
in PBS. As can be seen in Fig. 4, for all strains tested, the reduced
GSH levels decreased proportional to farnesol concentration
(Fig. 4A). Strikingly, at 0F the FL3 strain exhibited the lowest levels
of GSH whereas cdr1 the maximum levels. This profile was
consistent in the presence of all farnesol concentrations tested.
Similarly, the intracellular GSSG content at 0F and all farnesol
concentrations was the highest in cdr1 and significantly lower in
FL3 (Fig. 4B). Based on the averaged content of reduced GSH and
GSSG, the maximum disruption in ratio was seen with FL3
followed by the CA whereas no or minimal changes were noted in
cdr1 (Fig. 4C).
ROS accumulation
The effect of farnesol was also evaluated microscopically via
assessment of ROS accumulation and necrosis following 3 h and
18 h exposure of CA and cdr1 cells in the absence and presence of
glutathione. Following incubation, cells were stained using a
combination of DCDHF-DA and propidium iodide. Confocal
images demonstrated no or minimal green or red fluorescence in
both strains following 3 h exposure to 40 mM farnesol (Fig. 5A).
However, at 200 mM a comparable number of CA and cdr1 cells
exhibited green or red fluorescence which was reduced upon
glutathione supplementation (Fig. 5A). Following 18 h exposure,
minimal (,1%) green fluorescence was seen in cdr1 at 40 mM
with more CA (5%) cells showing green fluorescence at that
concentration (Fig. 5B). In contrast, at 200 mM, the majority
(.90%) of CA cells were red with few green cells compared to
only few green (10%) and red (,2%) cdr1 cells (Fig. 5B).
However, in the presence of glutathione, significantly less
fluorescent CA (50% red) and cdr1 (,1% green) cells were seen
(Fig. 5B). Values represent the average counts of cells from 10
fields.
Caspases activation
As the presence of activated intracellular caspases is indicative of
activation of an apoptotic process, CA cells were exposed to
200 mM farnesol in the absence and presence of exogenous
glutathione to assess whether glutathione modulates the apoptotic
effect of farnesol on the cell. Images revealed the presence of green
fluorescence in the farnesol-exposed cells indicating activation of
intracellular caspases. However, glutathione addition significantly
inhibited the activation of intracellular caspases (Fig. 6).
Changes in glutathione metabolic enzymes activity
Depletion of intracellular GSH levels due to farnesol exposure
is expected to activate enzymatic reactions in the glutamyl cycle
as a compensatory mechanism for depletion. Therefore, the levels
of activity of glutathione peroxidase (GPX) and glutathione
reductase (GLR), key enzymes involved in glutathione metabo-
lism were measured. Results from these assays demonstrated an
increase in intracellular GPX activity in CA proportional to
farnesol concentration and exposure time (Fig. 7A). In contrast,
no change in activity was noted with cdr1 following 3 h exposure
to farnesol with increase observed at 18 h. Upon glutathione
supplementation however, the level of GPX enzyme in both
strains was reduced to near baseline levels at both time points.
Similar to GPX, in both strains, GLR activity significantly
increased in a manner proportional to farnesol concentration
following 18 h exposure, however, at 3 h the level of GLR
activity remained at baseline levels (Fig. 7B). In general and
Figure 3. Effect of CDR1 overexpression on the response to farnesol toxicity using the MTS viability assay. Significant increase in
susceptibility to farnesol in FL3 strain following induction of CDR1 overexpression with the strains lacking the CDR1 gene demonstrating enhanced
tolerance. Error bars indicate the standard errors of the means. p,0.05.
doi:10.1371/journal.pone.0028830.g003
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higher in CA compared to cdr1 with levels returning to baseline
with glutathione at 3 h exposure. In contrast, at 18 h, although
GLR level was drastically reduced with glutathione, it remained
significantly higher than baseline (Fig. 7B).
The observed differential increase in both enzyme activities in
response to farnesol was consistent with results from RT-PCR
analysis of C. albicans GPX2 and GLR1 genes following 3 and 18 h
exposure to farnesol (Fig. S6).
Expression of the SOD genes
As the C. albicans Sods are the primary enzymatic antioxidants
involved in protection against ROS, it is expected that their
expression is modulated by ROS accumulation in the cell.
Therefore, to evaluate the response of C. albicans to oxidative
stress, expression of the SOD genes was assessed in CA and cdr1
following 3 (Fig. 8A) and 18 h (Fig. 8B) exposure to farnesol.
Results from these experiments demonstrated variable but
significant upregulation in the SOD genes in the parent strain at
Figure 4. Effect of farnesol on intracellular GSH/GSSG homeostatis and redox balance. Significant reduction in GSH levels proportional to
farnesol concentration with FL3 exhibiting lowest levels and highest disruption in ratio whereas cdr1 had highest GSH levels with minimal changes in
ratio noted. Error bars indicate the standard errors of the means.
doi:10.1371/journal.pone.0028830.g004
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PLoS ONE | www.plosone.org 8 December 2011 | Volume 6 | Issue 12 | e28830Figure 5. Representative confocal scanning laser fluorescent images of CA and cdr1 cells stained for ROS accumulation and necrosis
following exposure to 40 and 200 mM farnesol in the absence (F) and presence (FG) of exogenous glutathione. (A) Minimal green (ROS
accumulation) and red (dead) fluorescence is seen in CA and cdr1 following 3 h exposure to farnesol whereas (B) the majority of CA cells were red
following 18 h exposure with significant decrease in fluorescence seen upon exogenous glutathione supplementation). In contrast, minimal
fluorescence was seen in cdr1 cells at 18 h. Bar represents 20 mm. p,0.05.
doi:10.1371/journal.pone.0028830.g005
Figure 6. Representative confocal scanning laser fluorescent images of C. albicans cells stained for intracellular caspase activation
following treatment with 200 mM farnesol in the absence (F) and presence (FG) of exogenous glutathione. Significant activation of
intracellular caspases in farnesol-exposed cells as indicated by green fluorescence with minimal fluorescence in cells treated with glutathione. Bar
represents 20 mm.
doi:10.1371/journal.pone.0028830.g006
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(data not shown). In contrast, no significant changes in expression
were seen in cdr1 following 3 h or 18 h exposure (Fig. 8A and B).
Discussion
Several key physiological roles have been described for the
quorum-sensing molecule farnesol in C. albicans cell cycle.
However, our previous investigations have shown that above
threshold concentrations, farnesol triggers a classical apoptotic
process causing death to the fungal cell [11]. Since farnesol is
described to be increasingly secreted by the fungus in aging
cultures, it is conceivable to speculate that through the regulation
of farnesol production, C. albicans cells may have developed a
mechanism of programmed cell death with evolutionary advan-
tages [35]. Therefore, the characterization of the mechanistic
Figure 7. Effect of farnesol on glutathione peroxidase (GPX) and glutathione reductase (GLR) intracellular enzyme activity in CA
and cdr1 following 3 h and 18 h exposure to increasing concentrations of farnesol. (A) Farnesol dose-dependent increase in GPX activity
in CA following 3 h and 18 h exposure to farnesol. Similar increase in cdr1 at 18 h with no change at 3 h (B) Increase in GLR activity in CA and cdr1 at
18 h with cdr1 exhibiting less activity than CA. In contrast, no effect on GLR activity was noted in both strains following 3 h exposure to farnesol.
However, activity of both enzymes was restored to near baseline levels in the presence of exogenous glutathione. In all experiments, GSH
supplementation maintained enzyme activity at normal baseline levels. Error bars indicate the standard errors of the means. p,0.05.
doi:10.1371/journal.pone.0028830.g007
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lead to the development of novel antifungal agents that switch on
endogenous cell suicide.
This current study was undertaken in order to elucidate a
defined mechanism behind the demonstrated farnesol-induced
apoptotic process in C. albicans. Specifically, experiments were
designed to validate the hypothesis that the mechanism of farnesol
toxicity involves consumption of the intracellular antioxidant GSH
and modulation of Cdr1p activity resulting in depletion of total
glutathione, oxidative stress and ultimately fungal cell death. The
effect of farnesol on intracellular glutathione level was clearly
demonstrated by measuring the levels of total glutathione with
simultaneous measurements of glutathione-metabolizing activities
in response to farnesol treatment. The combined results from these
experiments revealed a farnesol concentration and exposure time-
dependent decrease in total glutathione levels, concomitant with
decrease in C. albicans viability (Fig. 2). However, exogenous GSH
supplementation not only maintained the intracellular glutathione
level and enhanced survival (Fig. 2), but also significantly
decreased ROS accumulation and caspase activation (Fig. 5 and
6). It is interesting to note that although GSH supplementation
almost completely inhibited killing by farnesol based on results
from the MTS assay (Fig. 2B), these results were not consistent
with those from the viability assay used based on plating and CFU
counts. Although CFU counts clearly demonstrated enhanced
tolerance to farnesol with GSH at all conditions tested (Fig. S4),
Figure 8. Effect of farnesol on the expression of the SOD1-4 genes in CA and cdr1 cells following 3 h and 18 h exposure to increasing
concentrations of farnesol as determined by qRT-PCR analysis. (A) Significant differential expression in SOD genes in CA at 3 h with no
significant variation in cdr1.( B) Similar but more pronounced expression profiles were seen at 18 h in both strains. Expression is normalized against
ACT1 as reference gene. Data represent the average of 3 independent experiments performed in triplicate. Error bars indicate the standard errors of
the means. p,0.05.
doi:10.1371/journal.pone.0028830.g008
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However, it is important to note that cells demonstrated enhanced
metabolic activity in the presence of GSH in the absence of
farnesol based on noted increase in absorbances (data not shown).
Therefore, the significant effect seen for GSH with MTS assay is
likely due to the enhanced metabolic activity of surviving cells and
therefore, assessment of viability based on CFU counts would be
the more accurate measure of GSH effect on cell survival.
To associate the observed decrease in GSH levels with Cdr1p
activity, gene expression studies were performed where CDR1
expression was shown to be significantly upregulated in the cells
exposed to farnesol in a concentration-dependent manner (Fig. 1).
Although the observed increase in CDR1 expression did not
change with glutathione supplementation, these results are
expected as CDR1 expression is induced by formation of
glutathione conjugates upon farnesol exposure. Therefore, al-
though exogenous GSH prevents intracellular depletion, the
impact of farnesol exposure on CDR1 expression remains. These
findings demonstrating farnesol modulation of expression of ABC
transporters were recently confirmed by a study by Sharama et al.
[36].
The involvement of Cdr1p was further established using a C.
albicans null mutant strain (cdr1) lacking CDR1. The combined
results demonstrated that, in contrast to CA, no significant decline
in intracellular glutathione levels was seen in cdr1, concomitant
with decreased farnesol-dependent killing at all concentrations and
time points tested. Alternatively, overexpression of CDR1 resulted
in enhanced killing of farnesol (30% increase) in FL3 cells
following induction of CDR1 (Fig. 3). These findings are intriguing
as paradoxically, the cdr1 strain is typically hypersusceptible to
azole drugs and several metabolic inhibitors and overexpression of
CDR1 has been shown to result in increased resistance to
fluconazole [27,37,38].
Collectively, these findings provide direct evidence for the
involvement of Cdr1p activity in farnesol cytotoxicity. It is
important to note however, that although overexpression of
CDR1 would be expected to confer resistance to fluconazole, in
our experience fluconazole MIC did not dramatically increase
upon CDR1 induction. However, although the MIC remained well
within the susceptible range, it was consistently higher following
induction. These results were not surprising as similarly, using the
microbroth dilution method Niimi et al. [30] also did not find
significant increase in fluconazole MIC. Furthermore, in our
study, the observed increase in farnesol-dependent killing of the
induced strain to farnesol was approximately 30%. Combined,
these findings indicate that although the level of CDR1 expression
obtained from the induction process was sufficient to confirm a key
role for CDR1 in farnesol cytotoxicity, it was not high enough to
confer resistance to fluconazole.
In contrast to cdr1, the cdr2 mutant demonstrated minimal
decrease in susceptibility to farnesol. The differences in farnesol
susceptibility between these mutant strains are not surprising, as
despite a high level of structural conservation, Cdr1p and Cdr2p
were shown to exhibit major functional differences and suscepti-
bility profiles to various antifungal agents, suggesting distinct
biological functions [27,39]. Specifically, Cdr1p was shown to
mediate the transport of human steroid hormone [37]. In addition,
it is important to note that in the absence of CDR2, CDR1 remains
functional and therefore a cdr2 mutant would be expected to
behave similarly to the wild type. Combined these findings
indicate that GSH efflux from cells is positively correlated with the
level of CDR1 expression.
In the cell, glutathione is synthesized and metabolized by the
reactions of the c-glutamyl cycle [18]. The two key enzymes
catalyzing these reactions are glutathione peroxidase (GPX) which
catalyzes the reduction of hydroperoxides by reduced glutathione
and glutathione reductase (GLR), a flavoprotein that catalyzes the
NADPH-dependent reduction of oxidized glutathione (GSSG) to
glutathione (GSH) [18]. GPX responds to oxidative stress
increasing cellular capability to produce GSSG, which would
need to be reduced back to GSH by the GLR enzyme or extruded
out of the cell by the action of efflux pumps (Fig. 9). In
combination, these two cellular strategies maintain adequate levels
of reduced cellular GSH. Therefore, increased GLR activity in the
cell serves as a compensatory mechanism by recycling GSSG to
GSH in order to maintain a high GSH/GSSG ratio. This ability
of both GPX and GLR to transcriptionally respond to oxidative
stress suggests the presence of a coordinated antioxidant cellular
response.
Therefore, in this study, experiments were also performed to
monitor the activity of GPX and GLR following initial and
prolonged exposure to farnesol. Results from these experiments
demonstrated a conspicuous activation of GPX in the wild-type
following 18 h exposure proportional to farnesol concentration,
with a less drastic increase following 3 h (Fig. 7A). In contrast,
although a similar increase in GPX activity was seen for the cdr1
mutant at 18 h, no change was noted upon initial exposure (3 h)
indicating no change in intracellular GSH levels at that time point,
consistent with the results from GSH measurement (Fig. 7A).
Similarly, GLR activity was increased in both the parent and
Figure 9. Proposed mechanism of farnesol cytotoxicity in C. albicans. Farnesol conjugates with reduced glutathione (GSH) forming
glutathione S-conjugate (F-GS) concomitant with oxidation of GSH to the disulfide form (GSSG), a reaction catalyzed by GPX. GSSG is reduced to GSH
by GLR as a recycling mechanism to maintain GSH levels. However, the oxidation and consumption of intracellular GSH coupled with Cdr1p-mediated
export of F-GS results in depletion of intracellular GSH, disruption of the redox balance and oxidative stress leading to apoptosis.
doi:10.1371/journal.pone.0028830.g009
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3 h exposure (Fig. 7B). These exposure time-associated differences
in GPX and GLR activity are expected as GPX is the first enzyme
to be activated in the cycle in response to farnesol to conjugate
toxic compounds to GSG producing GSSG. However, as GSSG
levels increase and GSH is depleted over time, GLR is activated as
a compensatory recycling system to maintain levels of reduced
GSH. Farnesol-induced depletion of intracellular glutathione
levels was corroborated by the findings demonstrating baseline
levels of both GPX and GLR upon exogenous glutathione
supplementation (Fig. 7).
In all eukaryotic cells, the cytoplasmic GSH content as well as
the GSH/GSSG redox status must be strictly regulated, since a
drastic reduction of GSH and the concomitant imbalance in
GSH/GSSG ratio causes severe cell mortality. This disruption in
cellular redox homeostatis was demonstrated using biochemical
assays to assess the disruption in GSH/GSSG ratio. Using
biochemical assays, results demonstrated significant reduction in
reduced GSH content proportional to farnesol concentration with
the strain over-expressing CDR1 demonstrating lowest intracellular
levels and the strain lacking CDR1 demonstrating highest levels
(Fig. 4). Based on the content of reduced GSH and GSSG, the
maximum disruption in ratio was seen with FL3 followed by the
CA whereas no or minimal changes were noted in the cdr1
(Fig. 4C). Taken together, these findings support the involvement
of farnesol-induced decrease in reduced GSH levels leading to
disruption of cellular redox status.
The increased resistance of cdr1 to oxidative stress conferred
upon farnesol exposure was corroborated by microscopic images
demonstrating decrease presence of intracellular ROS accumula-
tion and apoptosis. Although the presence of cells under oxidative
stress and apoptosis was comparable for CA and cdr1 at 3 h
exposure, at 18 h a dramatic difference in response to 200 mM
farnesol was noted between the two strains where the majority of
CA cells were dead (Fig. 5). The counter effect of exogenous
glutathione however, was seen in both strains under all conditions
tested (Fig. 5). Interestingly, although at 40 mM farnesol resulted in
significant killing of C. albicans as demonstrated by viability assays,
the microscopic images are not reflective of that level of adverse
effect at that concentration. However, it is important to note that
killing assays were performed in PBS in 96-well microtiter plates
whereas for ROS staining, the cells were grown in media in the
presence of farnesol. Nevertheless, the trend of the results from the
various assays is consistent with the notion that farnesol exerts a
concentration and exposure time-dependent cytotoxic effect which
is alleviated by exogenous glutathione and is less dramatic in the
absence of Cdr1p.
As clearly demonstrated by us and others, farnesol stimulates
the production of ROS which can damage almost every essential
cellular component [11,14,40,41]. Therefore, fungal cells have
evolved specific defense mechanisms to neutralize ROS. The
primary enzymatic antioxidants involved in protection against
ROS are a family of cytoplasmic and mitochondrial superoxide
dismutases (Cu-Zn and Mn-SODs), which act directly as ROS
detoxifiers [14,41–43]. The combined indicators of a decreased
response to oxidative stress in the cdr1 strain compared to the
parent strain prompted us to evaluate the gene expression profile
of enzymes crucial for defense against oxidative stress in C. albicans.
Quantitative RT-PCR analysis demonstrated significant up-
regulation of the SOD1-4 genes in the parent strains in response
to 3 and 18 h exposure to farnesol (Fig. 8). Strikingly, no
significant differences in the expression of the SOD genes was
noted in the cdr1 strain, supporting the overall indicators of
decreased response to oxidative stress in the absence of Cdr1p.
The mechanism behind the noted differences in the expression
of the various SOD genes is not quite clear. However, Sod2p is
primarily responsible for scavenging intracellularly produced
superoxides and therefore, SOD2 would be expected to be
upregulated in response to intracellular ROS accumulation the
result of farnesol exposure [43]. In addition, C. albicans seems to
coordinate the production of CuZnSOD (SOD1) and MnSOD
(SOD2) in a reciprocal manner which is seen in our findings [43].
On the other hand, SOD3 was shown not to be stimulated by drug-
induced oxidative stress but rather to be involved in the protection
against reactive oxygen species during the stationary phase and
therefore, is induced upon entry and during stationary phase
[43,44]. This is also consistent with our results where SOD3
expression seemed to increase at the 18 h growth period but not at
3 h. Therefore, the observed overexpression of this gene may not
be in response to farnesol but rather to entry into a stationary
phase. Alternatively, although the function of the Sod4p
isoenzyme remains to be established, SOD4 is regulated during
phenotypic switching [43]. Therefore, SOD4 expression is not
expected to be affected as the experiments were performed on
yeast cultures. The ambiguity of the expression profiles of the SOD
genes in response to farnesol is further complicated by the
observed response upon exogenous glutathione supplementation,
where no significant changes were noted in the absence and
presence of glutathione. Although a decrease in expression would
be expected, it is important to note that GSH supplementation
alleviated the oxidative stress exerted by farnesol on the cell as
shown by the results from the various experiments but did not
completely neutralize the damaging effect. Therefore, it is more
logical to expect that the cell will continue to respond to the stress
via SOD gene regulation.
Taken together, the findings presented here indicate that the
enhanced overall resistance of the cdr1 mutant to farnesol-
dependent killing is prominent during early stages of exposure to
moderate farnesol concentrations. As the concentration of farnesol
increases and exposure time is prolonged, farnesol toxicity
increases in the cdr1 strain. However, it is important to note that
the hydrophobic nature of farnesol favors its accumulation in
microbial cell membranes, resulting in disruption of membrane
integrity, as we have previously demonstrated in C. albicans and in
the bacterial pathogen Staphylococcus aureus [11,45]. Therefore, it is
likely that at high concentration, farnesol causes extensive
disruption of the cell membrane leading to immediate cell death
or necrosis. Alternatively, at lower concentrations, farnesol toxicity
is mediated via disruption of the intracellular redox balance and
ROS accumulation. Therefore, it is probable that necrosis and
apoptosis are occurring simultaneously, which may explain the
initial enhanced toxicity of farnesol observed in the cdr1 mutant.
In conclusion, the combined findings from this study provide
evidence that farnesol reduces intracellular levels of GSH via
Cdr1p export from the intracellular compartment, resulting in
glutathione depletion and disruption of the redox balance.
However, absence of CDR1 allows cells to maintain appropriate
levels of total intracellular GSH and redox potential promoting
cell survival and function. Although Cdr1p may serve as an
immediate mechanism for the cell to eliminate oxidized species,
this process, if stimulated for a prolonged period, may reduce the
total intracellular thiol pool and paradoxically have an undesirable
effect on the intracellular ratio of GSH/GSSG and cell function.
We would like to note that the instability of the farnesol-GSH
conjugate formed has made it problematic to measure its levels
intracellularly and extracellularly and therefore, this aspect
remains speculative. However, we expect the novel findings
presented here to pave the way for more studies where sensitive
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conjugates.
To our knowledge, this is the first study elucidating a defined
mechanism behind farnesol-induced apoptosis in C. albicans. These
findings will enable a better understanding of the molecular
mechanisms underlying farnesol-mediated cytotoxicity in eukary-
otic cells. Therefore, further investigations are warranted to
explore the potential of this redox-cycling agent as an alternative
antifungal agent.
Supporting Information
Figure S1 Complementation of CDR1 inactivation analyzed by
(A) Western analysis with a Cdr1p antibody. Wild type Cdr1p
signal is restored in the revertant DSY4481 and (B) drug resistance
phenotype. Wild type fluphenazine susceptibility is restored in the
revertants (two independent transformants were spotted).
DSY4481. Strains designation: DSY4310: CAF4-2 transformed
with CIP10; DSY4480: DSY449 transformed with CIP10;
DSY4481: DSY449 transformed with pDS1765.
(TIF)
Figure S2 C. albicans cell density killing curve. Percent killing of
C. albicans by farnesol was inversely proportional to cell density.
Error bars indicate the standard errors of the means.
(TIF)
Figure S3 Time course killing of C. albicans by farnesol. Percent
killing of C. albicans was proportional to time of exposure to
farnesol. However, the difference in level of killing between the
different time points was not significant. Error bars indicate the
standard errors of the means.
(TIF)
Figure S4 C. albicans viability as assessed by plate dilution
method. Percent killing of C. albicans based on CFU counts is
proportional to farnesol concentration and time of exposure with
enhanced tolerance to farnesol upon GSH supplementation. Error
bars indicate the standard errors of the means.
(TIF)
Figure S5 RT-PCR gene expression analysis of C. albicans strains
following induction of CDR1. Significant increase in the expression
of CDR1 in the induced FL3 compared to wild-type with no
expression detected in the strains lacking the CDR1 gene (cdr1 and
DL1).
(TIF)
Figure S6 RT-PCR gene expression analysis of C. albicans GPX2
and GLR1 following 3 and 18 h exposure to farnesol. Significant
increase in the expression of both genes at 18 h whereas only
GPX2 is increased at 3 h.
(TIF)
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